Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial
Sarah Pyne(University of East Anglia), Miriam Santer(NIHR Southampton Biomedical Research Centre), Natalia Permyakova(University Hospital Southampton NHS Foundation Trust), Matthew J Ridd(University of Bristol), Paul Little(University of Antwerp), Ingrid Müller(University of Southampton), Tracey Sach(University of East Anglia), Zina Eminton(University of Southampton), Irene Soulsby(University of Southampton), Alison Layton(University of York), Karen Thomas(University of Nottingham), Megan Lawrence(University Hospital Southampton NHS Foundation Trust), Susanne Renz(University Hospital Southampton NHS Foundation Trust), Gareth Griffiths(NIHR Evaluation Trials and Studies Coordinating Centre), Beth Stuart(Queen Mary University of London), Nick Francis(University of Oxford), Jacqui Nuttall(University of Southampton), Kim S Thomas(University of Nottingham)
Cited by 5
Related Papers
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
|The Lancet|2009|1.5k
New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group
|Journal of the American Academy of Dermatology|2009|835
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
|The Lancet|2007|570
Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial
|The Lancet|2013|440
European Evidence‐based (S3) Guidelines for the Treatment of Acne
|Journal of the European Academy of Dermatology and Venereology|2012|422